H.C. Wainwright Reiterates Buy on Minerva Neurosciences, Lowers Price Target to $20

H.C. Wainwright reiterates Minerva Neurosciences (NASDAQ:NERV) with a Buy and lowers the price target from $22 to $20.

Benzinga · 12/19/2019 12:13

H.C. Wainwright reiterates Minerva Neurosciences (NASDAQ:NERV) with a Buy and lowers the price target from $22 to $20.